Annual report pursuant to Section 13 and 15(d)

Consolidated Income Statements

v3.22.1
Consolidated Income Statements - USD ($)
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue    
Total revenue $ 6,010,438 $ 4,825,956
Cost of sales 4,138,785 3,299,315
Gross profit 1,871,653 1,526,641
Selling, general and administrative expenses 2,275,989 2,600,745
Operating income (loss) (404,336) (1,074,104)
Other income and (expense)    
Gain (loss) on investments in securities 1,017 (14,961)
Realized gain on sale of GlauCanna rights 31,000
Recovery (impairment) of investments 22,718 (139,148)
Interest income 70,229 92,571
Interest expense (62,392) (35,295)
Gain (loss) on equipment disposal 86 67
Paycheck protection program loans forgiven 87,122 452,348
EIDL grant 10,000
Other income (expense) 38,870 10,031
Total other income and (expense) 157,650 406,613
Income (loss) before provision for income taxes (246,686) (667,491)
Provision for income taxes 9,780 10,050
Net income (loss) (256,466) (677,541)
Gain (loss) attributable to non-controlling interest 16,382 48,484
Net income (loss) attributable to Mentor $ (272,848) $ (726,025)
Basic and diluted net income (loss) per Mentor common share:    
Basic and diluted $ (0.012) $ (0.032)
Weighted average number of shares of Mentor common stock outstanding:    
Basic and diluted 22,850,947 22,850,947
Service [Member]    
Revenue    
Total revenue $ 5,969,674 $ 4,778,249
Finance Lease Revenue [Member]    
Revenue    
Total revenue $ 40,764 $ 47,707